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The biological functions of folic acid (FA) including the prevention of neural tube defects in developing embryos and 
synthesis of DNA and its repair, have been well reported in literature. As a result; the fortification of folic acid into 
many daily foods in Canada such as wheat and cereals is mandatory. We have shown that over-dosage of FA causes 
blood haemolysis, leading to progressive anaemia. It is reported that 200 – 400 µg/ml of FA increases the size of 
blood cells within 2h of treatment, also leading to abnormal cell division and necrosis (in vitro concentrations). This 
observation suggests early cell senescence. We hypothesized that FA may play a vital role in cellular senescence. 
5th generation Kidney fibroblast (COS-7) cells were treated with 200 µg of FA in combination with an anti-neoplastic 
agent, nocodazole- prior to FA treatment. FA increased the expression of fibronectin (protein marker for aging) of 
nocodazole treated cells. Furthermore, fibronectin expression was higher in FA-treated cells of the 14th generation 
compared to the 8th generation. 14th generation cells also showed a larger decrease in cell size when exposed to 
FA. This suggests FA over-dosage has an affect on the cell growth cycle. 
INTRODUCTION: 
The significance of folic acid (FA) in biological functions 
like biosynthesis of nucleotides and re-methylation of 
homocysteine, and synthesis of DNA and its repair has 
been reported in many cell types. Studies have shown 
that folic acid acts as a co-factor, and helps in cell 
division and growth (Wagner, 1995). Folate deficiency 
is correlated to serious health problems including neural 
tube defects in developing embryos (Wolff & others, 
2009). Therefore women consume FA during early 
stages of pregnancy. FA also helps in the production of 
red and white blood cells, and its deficiency may lead 
to anemia, leading to fatigue, weakness and inability to 
concentrate (Zalusky & Herbert, 1961). 
In the field of aging, FA is a largely debated topic. 
While many articles and health websites suggest 
FA supplements decrease the rate of aging, several 
researchers believe FA plays detrimental roles in 
the health of certain patients. Canada, the USA, and 
many other nations currently fortify foods such as 
wheat and cereals with FA. It is also a readily available 
over-the counter drug. Therefore the uncontrolled/
unaccounted consumption of FA is increasing day by 
day (Choumenkovitch et al., 2002).
We previously observed that FA over-dosage causes 
blood haemolysis, a positive sign for progressive 
anemia. 200–400μg/ml of FA caused an abnormal 
blood cell division and necrosis suggesting early cell 
senescence (unpublished data). 
Cellular Senescence is a state of permanent cell-growth 
arrest resulting from transitions and accumulations of 
deleterious cell aging processes including stress and 
damage. Cells derived from embryonic tissues can 
only divide to a finite number of times known as the 
Hayflick limit (Hayflick & Moorhead, 1961). After a 
certain amount of cell division the cells adopt a state of 
senescence where cell growth is limited due to a cell 
growth arrest program, leading to an irreversible loss 
of cell division (reviewed in Hayflick, 1985; Hayflick, 
1994). As cells approach this limit in cell division they 
accumulate fibrous proteins like fibronectin (Kumazaki 
et al., 1991; Dumont et al., 2000). 
I hypothesize that FA influences cellular senescence 
in COS-7 cells. In order to investigate this, viability, 
morphology and senescence (Hayflick 1961, 1985, 
1994) were examined. Fibronectin levels of COS-7 
cells with and without supplementation of the anti-
neoplastic stress agent; Nocodazole were assessed 
by Dot-blot Assay using anti-fibronectin antibody (Vera-
Cabrera L & Others 1999). The anti-neoplastic agent 
inhibits cell division and hence further ages the COS-
7 cells. The cells were exposed to FA, Nocodazole 
and/or a combination of the two treatments. Similar 
experiments were conducted with COS-7 cells from two 
different generations, P8 and P14.
INTRODUCTION: 
The significance of folic acid (FA) in biological functions 
like biosynthesis of nucleotides and re-methylation of 
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FA RESCUES CELLS FROM NOCODAZOLE-INDUCED 
CELL DEATH PROCESS:
Figure 1. 
Viability was assessed using Trypan Blue assay. Data was 
recorded, mean ± SD values was calculated and t-test was 
applied (P<0.05):
FA treatment individually caused only minimal changes 
in the cell viability compared to untreated 5th generation 
COS-7 cells. The nocodazole treated cells showed 
dramatic decrease in cell viability; which is understandable 
since the anti-neoplastic agent is supposed to inhibit cell 
division and hence further age the cells. Addition of FA, to 
the cells pretreated with nocodazole seemed to rescue the 
cells from the damaging effects of the anti-neoplastic agent 
and increased cell viability
homocysteine, and synthesis of DNA and its repair has 
been reported in many cell types. Studies have shown 
that folic acid acts as a co-factor, and helps in cell 
division and growth (Wagner, 1995). Folate deficiency 
is correlated to serious health problems including neural 
tube defects in developing embryos (Wolff & others, 
2009). Therefore women consume FA during early 
stages of pregnancy. FA also helps in the production of 
red and white blood cells, and its deficiency may lead 
to anemia, leading to fatigue, weakness and inability to 
concentrate (Zalusky & Herbert, 1961). 
In the field of aging, FA is a largely debated topic. 
While many articles and health websites suggest 
FA supplements decrease the rate of aging, several 
researchers believe FA plays detrimental roles in 
the health of certain patients. Canada, the USA, and 
many other nations currently fortify foods such as 
wheat and cereals with FA. It is also a readily available 
over-the counter drug. Therefore the uncontrolled/
unaccounted consumption of FA is increasing day by 
day (Choumenkovitch et al., 2002).
We previously observed that FA over-dosage causes 
blood haemolysis, a positive sign for progressive 
anemia. 200–400μg/ml of FA caused an abnormal 
blood cell division and necrosis suggesting early cell 
senescence (unpublished data). 
Cellular Senescence is a state of permanent cell-growth 
arrest resulting from transitions and accumulations of 
deleterious cell aging processes including stress and 
damage. Cells derived from embryonic tissues can 
only divide to a finite number of times known as the 
Hayflick limit (Hayflick & Moorhead, 1961). After a 
certain amount of cell division the cells adopt a state of 
senescence where cell growth is limited due to a cell 
growth arrest program, leading to an irreversible loss 
of cell division (reviewed in Hayflick, 1985; Hayflick, 
1994). As cells approach this limit in cell division they 
accumulate fibrous proteins like fibronectin (Kumazaki 
et al., 1991; Dumont et al., 2000). 
I hypothesize that FA influences cellular senescence 
in COS-7 cells. In order to investigate this, viability, 
morphology and senescence (Hayflick 1961, 1985, 
1994) were examined. Fibronectin levels of COS-7 cells 
with and without supplementation of the anti-neoplastic 
stress agent; Nocodazole were assessed by Dot-blot 
Assay using anti-fibronectin antibody (Vera-Cabrera 
L & Others 1999). The anti-neoplastic agent inhibits 
cell division and hence further ages the COS-7 cells. 
The cells were exposed to FA, Nocodazole and/or a 
combination of the two treatments. Similar experiments 
were conducted with COS-7 cells from two different 
generations, P8 and P14. 
RESULTS: 
FA rescues cells from nocodazole-induced cell death 
process and drives cellular senescence: 
FA treatment caused only minimal changes in the 
cell viability compared to untreated 5th generation 
COS-7 cells. Addition of FA, to the cells pretreated 
with nocodazole seemed to rescue the cells from the 
damaging effects of the anti-neoplastic agent and 
increased cell viability (Fig. 1). Dramatic changes in cell 
sizes occurred with FA treatment. In both the naturally 
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IN NOCODAZOLE PRE-TREATED COS-7 CELLS, FOLIC 
ACID EXPOSURE LEADS TO ABNORMAL INCREASE 
IN CELL SIZE:
Figure 2. 
a) 2 hours after treatment, pictures were captured using 
a camera attached to the microscope and analyzed 
using Image-J software.
b) FA treatment individually did not cause any prominent 
changes in cell sizes. 
c) The nocodazole pre-treated cells showed swelling 
present in the cells.
d) The exposure of FA to the sizes even further. It 
is speculated that this was caused due to protein 
synthesis within the cells. Nocodazole pre-treated 
cells enlarged the cell
IN NOCODAZOLE PRE-TREATED COS-7 CELLS, FOLIC 
ACID DRIVES CELLULAR SENESCENCE:
Figure 3. 
Senescence was investigated by Dot-blot Assay using 
anti-fibronectin antibody. Data was recorded, mean ± SD 
values was calculated and t-test was applied (P<0.05):
a) Developed x-ray film of protein blots, displaying anti-
fibronectin antibodies: Fibronectin expression of each 
blot is dependant on blot intensity which was analyzed 
with Image-J software.
b)  FA individually did not have any significant impact 
upon the fibronectin expression of the cells, but 
nocodazole decreased expressions. This impact 
most likely occurred due to the reduced cell numbers 
caused by the anti-neoplastic agent. Folic acid 
supplementation increased the fibronectin expression 
in nocodazole pre-treated P5 generation COS-7 cells. 
This appears to represent a phase in the cell growth 
process where cells undergo proliferation, but are 
also steered towards aging
growing and nocodazole-pre-treated cells, FA treatment 
caused large increase in cell sizes. A more prominent 
occurring of this effect was observed in nocodazole-
pre-treated cells (Fig 2). Folic acid supplementation 
increased the fibronectin expression in nocodazole pre-
treated COS-7 cells. Combined these results possibly 
represent a phase in the cell growth process where are 
steered towards senescence (Fig. 3). 
Older generations show a larger increase in FA 
induced expression of fibronectin: 
When compared to naturally aging cells of generations 
P8 and P14, FA treatment promotes increased cell 
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FA TREATMENT DID NOT HAVE ANY SIGNIFICANT 
EFFECTS ON THE CELL VIABILITY OF THE 
GENERATIONS:
Figure 4. 
Viability was assessed using Trypan Blue assay. Data was 
recorded, mean ± SD values was calculated and t-test was 
applied (P<0.05):
No prominent differences in cell viability was observed in 
either of the cell generations; possibly due to experimental 
conditions. 
FA REDUCED CELL SIZES IN BOTH GENERATIONS, 
BUT WITH A LARGER EFFECT SHOWN ON THE P14 
GENERATION:
Figure 5. 
2 hours after treatment, pictures were captured using a 
camera attached to the microscope and analyzed using 
Image-J software. Data was recorded, mean ± SD values 
was calculated and t-test was applied (P<0.05):
A slight decrease in cell sizes was observed in the FA treated 
P8 cells, but was noted as insignificant. In the FA treated 
P14 cells a much more significant decrease in cell size was 
noticed, suggesting that FA has a more prominent impact on 
the older cell generations.
aging. FA treatment did not have any significant 
effects on the cell viability of the generations (Fig. 4), 
although it has significant effects on the cell sizes. 
FA reduced cell sizes in both generations, but with a 
larger effect shown on the P14 generation of cells (Fig. 
5). Similarly, FA treatment increased the fibronectin 
expressions in both the P8 and P14 generation 
of COS-7 cells, but the trend was again greater in 
the P14 cells (Fig. 6). This suggests that FA has a 
negative impact on both young and older generations 
of cells, but its impacts on older generations are far 
more damaging and drastic.
DISCUSSION:
FA is a common dietary supplement consumed by 
many people around the world. Although widely 
debated, many nations including Canada and the 
US are currently fortifying foods such as wheat and 
cereals with FA. Due to opinions in various media 
sources many individuals consume FA as an additional 
dietary supplement in the belief that it reduces the 
cell aging process. Consumption of FA is increasing 
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FA TREATMENT INCREASED THE FIBRONECTIN 
EXPRESSIONS IN BOTH THE P8 AND P14 GENERATION, 
BUT THE TREND WAS GREATER IN THE P14 CELLS :
Figure 6. 
Senescence was investigated by Dot-blot Assay using anti-
fibronectin antibody. Data was recorded, mean ± SD values 
was calculated and t-test was applied (P<0.05):
a) Developed x-ray film of protein blots, displaying anti-
fibronectin antibodies: Fibronectin expression of each 
blot is dependant on blot intensity which was analyzed 
with Image-J software.
b) FA treatment increased the fibronectin expressions in 
both the P8 and P14 generation of Cos-7 cells, but 
the trend was again greater in the P14 cells, suggesting 
that FA has a negative impact on both young and older 
generations of cells, but its impacts on older generations 
are far more damaging and drastic.
in unprecedented levels with limited research into 
negative side-effects (Choumenkovitch et al., 2002). 
We have previously demonstrated the harmful effects 
of FA over-dosage (200µg-800µg) on blood cells which 
include blood haemolysis, abnormal cell division and 
necrosis. These current findings suggest that FA plays 
a large role in cell senescence process- but its effects 
are dependent on type of senescence (natural vs. 
induced). FA should therefore be carefully administered 
depending on the health status of an individual. 
FUTURE DIRECTIONS: 
FA is a drug that may have cell specific effects. 
Therefore I want to test the affects of FA on various 
cell types. A study has illustrated that FA plays an 
important role towards the chemoprevention of gastric 
carcinogenesis by enhancing apoptosis of epithelial 
cells in the gastric cancer patients (Cao et al., 2005). 
A is often recommended and prescribed in cancer-like 
disease cases to help support a patient’s red blood cell 
production. However, FA over-dose can have deleterious 
effects in certain cancers (Ebbing M et al., 2009); 
suggesting a dual role in cancer-protection against 
tumor initiation and progression of pre-neoplastic cells 
(Smith et al., 2008; Young-In Kim, 2008). Future studies 
will investigate these specific issues. 
MATERIALS AND METHODS: 
COS-7 cells (Kidney Fibroblast Cell line; African Green 
Monkey) were cultured through standard protocols until 
enough cells were obtained to perform viable tests. 
Equal amounts of cell suspension, 1 x 106 cells/well, 
were used during each test. Then, in order to study 
FA’s impacts on stressed and naturally aging COS-7 
cells, cells were either pre-treated (2h) with 100µg/ml 
nocodazole with/without the presence of 200 μg/ml FA 
in buffered saline (pH 7.2), and/or treated with 200 μg/
ml FA in buffered saline individually. All experiments 
were carried out in triplicates. 
Cell Proliferation: 
The number of cells was calculated by a 
haemocytometer. For each dosage, 10µl of cell 
suspension was loaded in the counting chamber and 
counted using a light microscope. 
Cell Viability:
0.4g of Trypan Blue Powder was dissolved into 
100ml of buffer saline to create Trypan Blue solution. 
Treated cells were stained with trypan blue dye 
(0.4%) and viewed under a light microscope. Cells 
with blue colour were considered as dead cells, while 
unstained cells as live cells. Both dead and live cells 
were counted using a haemocytometer, and the living 
cell percentage or viability was calculated. 
Cell Morphology: 
Cells were additionally stained with haematoxylin & 
eosin dye to visualize cell morphology under a light 
microscope. Pictures were captured using a camera 
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attached to the microscope and analyzed using 
Image-J software (Schneider, 2012). 
Cell Senescence: 
Treated cells were collected and centrifuged at 
12000RPM for 10 min to isolate protein samples. 
Protein samples were distributed on nitro-cellulose 
paper (NCP) and blocked with 5% skimmed milk re-
suspended in 15ml phosphate buffered saline-tween 
20 (PBS-T). The blot was washed 3 times with PBS-T 
and treated with a primary and secondary antibody 
to bind with fibronectin (Anti-Mouse Fibronectin; Goat 
anti-Rabbit). Blot was then treated with 1ml Peroxide 
Solution to react to anti-bodies and 1ml Luminal 
Enhancer to cause chemiluminescence of anti-
bodies when exposed to light. NCPs were developed 
on x-ray films and intensity of each blot on film was 
analyzed with Image-J software.
ABBREVIATIONS:
DNA  Deoxyribonucleic acid
UV  Ultra Violet
FA  Folic Acid
PBS-T  Phosphate Buffer Saline – Tween 20
Key Words: folic acid; cellular senescence; dietary 
fortification; kidney fibroblast cells 
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